|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.440 USD | -1.37% |
|
-10.56% | -27.64% |
| Market Cap | 383M 335M 309M 285M 537M 36.91B 549M 3.69B 1.45B 18.08B 1.44B 1.41B 62.23B | P/E 2026 * |
-1.62x | P/E 2027 * | -2.28x |
|---|---|---|---|---|---|
| Enterprise Value | 344M 300M 277M 255M 482M 33.1B 492M 3.31B 1.3B 16.21B 1.29B 1.26B 55.81B | EV / Sales 2026 * |
2.67x | EV / Sales 2027 * | 2.26x |
| Free-Float |
3.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Autolus Therapeutics plc
| 1 day | -1.37% | ||
| 1 week | -10.56% | ||
| Current month | -10.00% | ||
| 1 month | -5.88% | ||
| 3 months | -10.00% | ||
| 6 months | +4.35% | ||
| Current year | -27.64% |
| 1 week | 1.4 |  | 1.57 |
| 1 month | 1.4 | | 1.74 |
| Current year | 1.18 | | 2.07 |
| 1 year | 1.18 | | 2.7 |
| 3 years | 1.1 | | 7.45 |
| 5 years | 1.1 | | 7.9 |
| 10 years | 1.1 | | 53.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Pulé
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/08/2014 |
Christian Itin
CEO | Chief Executive Officer | 61 | 29/02/2016 |
Robert Dolski
DFI | Director of Finance/CFO | 56 | 06/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
John Berriman
BRD | Director/Board Member | 78 | 31/07/2014 |
William Young
BRD | Director/Board Member | 81 | 14/11/2021 |
Cynthia Butitta
BRD | Director/Board Member | 71 | 28/02/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/06/26 | Free | Director | 79,167 | 0.0477% | ||
| 29/06/26 | Free | Director | 79,167 | 0.0477% | ||
| 29/06/26 | Free | Chairman | 79,167 | 0.0477% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -10.56% | -40.50% | -42.40% | 383M | |
| -0.33% | +1.83% | +23.03% | -6.22% | 68.85B | |
| +0.67% | +0.93% | +37.53% | +198.53% | 52.13B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | |
| +1.12% | +0.35% | -50.35% | -52.35% | 41.24B | |
| -1.40% | +3.43% | +60.07% | -26.01% | 30.41B | |
| -2.11% | -9.45% | +91.99% | -49.58% | 24.53B | |
| +0.51% | +0.46% | +70.08% | +91.96% | 23.42B | |
| -5.57% | -0.84% | -0.17% | +174.11% | 19.75B | |
| -0.86% | -1.99% | +68.42% | +124.39% | 16.57B | |
| Average | -0.84% | -1.78% | +29.97% | +45.20% | 32.07B | |
| Weighted average by Cap. | -0.34% | -0.08% | +31.26% | +47.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 112M 104M 95.57M 180M 12.38B 184M 1.24B 487M 6.06B 483M 472M 20.88B | 191M 167M 154M 142M 268M 18.39B 274M 1.84B 724M 9.01B 717M 701M 31.01B |
| Net income | -242M -212M -195M -180M -340M -23.34B -347M -2.34B -919M -11.43B -910M -890M -39.35B | -185M -161M -149M -137M -259M -17.79B -265M -1.78B -700M -8.71B -694M -678M -29.99B |
| Net Debt | -39.53M -34.55M -31.88M -29.38M -55.38M -3.81B -56.61M -381M -150M -1.86B -148M -145M -6.42B | 48.41M 42.31M 39.04M 35.99M 67.83M 4.66B 69.33M 467M 184M 2.28B 182M 178M 7.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | US$1.440 | -1.37% | 760,292 |
| 16/07/26 | US$1.460 | -3.31% | 1,112,732 |
| 15/07/26 | US$1.510 | +4.14% | 1,442,552 |
| 14/07/26 | US$1.450 | -2.03% | 3,005,274 |
| 13/07/26 | US$1.480 | -8.07% | 2,092,968 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AUTL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
